ArticleSensors (Basel, Switzerland)2025
SMART MAT: Fibre Optic Innovation for Bedside Monitoring and Validation of Continuous Vital Signs.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vital sign monitoring is fundamental to patient care. Although traditional intermittent systems are flawed, barriers to implementing continuous monitoring systems remain. The SMART MAT is a novel continuous monitoring device that detects vital signs remotely via fibre optic technology. The study aims to validate the SMART MAT and its paired devices against gold/clinical standard measurements for measuring heart rate (HR), respiratory rate (RR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and oxygen saturation (SpO2). Healthy adults aged 21 to 80 were recruited for this cross-sectional study. Participants rested supine on a standardised mattress with the SMART MAT below. Vital signs were recorded over three five-minute intervals. Statistical analysis included descriptive statistics, two-way ANOVA, Mean Absolute Percentage Error (MAPE), and Bland-Altman plots. Among 321 participants recruited, HR and most RR measurements saw non-statistically significant differences (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.